Proactive outreach for tobacco cessation in BIPOC populations
A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities
This study is testing a new way to help people in BIPOC communities quit smoking by reaching out to them directly and connecting them with effective support and treatments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Minnesota Academic / other |
| Locations | 3 sites (Minneapolis, Minnesota and 2 other locations) |
| Trial ID | NCT05671380 on ClinicalTrials.gov |
What this trial studies
This project evaluates a proactive outreach intervention aimed at improving tobacco cessation among BIPOC populations who smoke, focusing on two health systems in the region. The study addresses the significant health disparities faced by BIPOC individuals in the U.S. regarding tobacco use and its consequences. By leveraging electronic health records, the intervention identifies patients who smoke and connects them with evidence-based cessation treatments through longitudinal proactive outreach. This multi-level approach seeks to enhance engagement and support for tobacco cessation in these underserved communities.
Who should consider this trial
Good fit: Ideal candidates include English or Spanish-speaking BIPOC adults who smoke more than one cigarette in the past 30 days and are patients within the participating healthcare systems.
Not a fit: Patients with documented cognitive impairment or those who have opted out of research studies may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly improve tobacco cessation rates among BIPOC populations, leading to better cardiovascular health outcomes.
How similar studies have performed: Other studies have shown success with proactive outreach and tailored interventions for tobacco cessation, particularly among underserved populations, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * English or Spanish-speaking BIPOC patients within the Hennepin Healthcare or MCHS system. BIPOC patients are any patients with a chart identified race that is not White, and will be verified by self-report from the baseline survey. * Currently smoke \>1 cigarette over the past 30 days * Must have address or telephone number in the electronic health record Exclusion Criteria: * Electronic health record documented cognitive impairment or legal guardianship * Patients who have opted out of reserach studies
Where this trial is running
Minneapolis, Minnesota and 2 other locations
- Hennepin Healthcare — Minneapolis, Minnesota, United States (Recruiting)
- University of Minnesota — Minneapolis, Minnesota, United States (Recruiting)
- Mayo Clinic Health System — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Steven Fu, MD, MSCE — Minneapolis Veterans Affairs Medical Center
- Study coordinator: Steven Fu, MD, MSCE
- Email: stevefu@umn.edu
- Phone: (612) 467-1979
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.